Combination of Proton Irradiation and Targeted Radionuclide Therapy with 177Lu-PSMA-617 in a Tumor Mouse Model of Prostate Cancer

被引：0
|
作者：
Mueller, C. [1 ]
Perrin, R. [1 ]
Umbricht, C. [1 ]
van der Meulen, N. [1 ]
Safai, S. [1 ]
Weber, D. [1 ]
Lomax, A. [1 ]
Schibli, R. [1 ]
机构：
[1] Paul Scherrer Inst, Villigen, Switzerland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-160
引用
收藏
页码：S180 / S181
页数：2
相关论文
共 50 条
  • [41] German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
    Rahbar, Kambiz
    Ahmadzadehfar, Hojjat
    Kratochwil, Clemens
    Haberkorn, Uwe
    Schaefers, Michael
    Essler, Markus
    Baum, Richard P.
    Kulkarni, Harshad R.
    Schmidt, Matthias
    Drzezga, Alexander
    Bartenstein, Peter
    Pfestroff, Andreas
    Luster, Markus
    Luetzen, Ulf
    Marx, Marlies
    Prasad, Vikas
    Brenner, Winfried
    Heinzel, Alexander
    Mottaghy, Felix M.
    Ruf, Juri
    Meyer, Philipp Tobias
    Heuschkel, Martin
    Eveslage, Maria
    Boegemann, Martin
    Fendler, Wolfgang Peter
    Krause, Bernd Joachim
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 : 257S - 262S
  • [42] Hematotoxicity after radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
    Zimbelmann, Stefanie
    Eppard, Elisabeth
    Hauser, Stefan
    Kuerpig, Stefan
    Yordanova, Anna
    Essler, Markus
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [43] Treatment of liver metastases of castration resistant prostate cancer with 177Lu-PSMA-617 and SIRT
    Seifert, Robert
    Boegemann, Martin
    Kahler, Michael
    Dittmann, Matthias
    Weckesser, Matthias
    Rahbar, Kambiz
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [44] Successful handling of an accidental extravasation of 177Lu-PSMA-617 in the treatment of advanced prostate cancer
    Jueptner, Michael
    Zuhayra, Maaz
    Assam, Isong
    Luetzen, Ulf
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2018, 57 (02): : N10 - N12
  • [45] Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Sun, Michael
    Niaz, Muhammad O.
    Nelson, Adlai
    Skafida, Myrto
    Niaz, Muhammad J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [46] Evaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)
    Pathmanandavel, Sarennya
    Crumbaker, Megan
    Ho, Bao
    Yam, Andrew O.
    Wilson, Peter
    Niman, Remy
    Ayers, Maria
    Sharma, Shikha
    Hickey, Adam
    Eu, Peter
    Stockler, Martin
    Martin, Andrew J.
    Joshua, Anthony M.
    Nguyen, Andrew
    Emmett, Louise
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (02) : 221 - 226
  • [47] First results with Lu-177-PSMA617 in targeted radionuclide therapy of patients with metastatic hormone-refractory prostate cancer
    Kratochwil, C.
    Giesel, F. L.
    Afshar-Oromieh, A.
    Benesova, M.
    Mier, W.
    Eder, M.
    Kopka, K.
    Haberkorn, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S130 - S130
  • [48] 225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
    Fadi Khreish
    Niklas Ebert
    Martin Ries
    Stephan Maus
    Florian Rosar
    Hendrik Bohnenberger
    Tobias Stemler
    Matthias Saar
    Mark Bartholomä
    Samer Ezziddin
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 721 - 728
  • [49] 225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
    Khreish, Fadi
    Ebert, Niklas
    Ries, Martin
    Maus, Stephan
    Rosar, Florian
    Bohnenberger, Hendrik
    Stemler, Tobias
    Saar, Matthias
    Bartholomae, Mark
    Ezziddin, Samer
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 721 - 728
  • [50] Circulating Tumor Cell -Based Molecular Biomarkers of 177Lu-PSMA-617 Treatment Efficacy in Metastatic Prostate Cancer
    Miyazawa, Y.
    Konik, A.
    Otani, K.
    Pittie, R.
    Chung, E.
    Rodden, D. J.
    Kelly, J. P.
    Shan, M.
    Xu, K. H.
    Otani, Y.
    Gan, X.
    Kako, B.
    O'Shea, A.
    Heidari, P.
    Dejan, J.
    Chevalier, N.
    Miller, M. A.
    Nieman, L.
    Ng, T. S. C.
    Miyamoto, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S70 - S71
12345